Literature DB >> 22193981

Stent thrombosis: understanding and managing a critical problem.

Julio F Marchini1, Andre Manica, Kevin Croce.   

Abstract

OPINION STATEMENT: Coronary artery stent thrombosis (ST), defined as the thrombotic occlusion of a stented segment, is an infrequent but serious complication of percutaneous coronary intervention (PCI). The clinical consequences of ST are severe, because acute stent occlusion results in myocardial infarction and death in up to 45% of cases. Specific patient and procedural characteristics increase the risk of ST, but optimized interventional techniques and antiplatelet therapies have the potential to decrease ST and improve cardiovascular outcomes following PCI.

Entities:  

Year:  2012        PMID： 22193981     DOI： 10.1007/s11936-011-0155-4

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN： 1092-8464


  105 in total

Review 1.  In-stent stenosis: pathology and implications for the development of drug eluting stents.

Authors:  Martin R Bennett
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

2.  Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data).

Authors:  Anthony A Bavry; Dharam J Kumbhani; Thomas J Helton; Deepak L Bhatt
Journal:  Am J Cardiol       Date:  2005-06-15       Impact factor: 2.778

3.  Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.

Authors:  Giuseppe Patti; Annunziata Nusca; Fabio Mangiacapra; Laura Gatto; Andrea D'Ambrosio; Germano Di Sciascio
Journal:  J Am Coll Cardiol       Date:  2008-09-30       Impact factor: 24.094

4.  Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting.

Authors:  Thomas Cuisset; Corinne Frere; Jacques Quilici; Pierre-Emmanuel Morange; Lyassine Nait-Saidi; Joseph Carvajal; Agnès Lehmann; Marc Lambert; Jean-Louis Bonnet; Marie-Christine Alessi
Journal:  J Am Coll Cardiol       Date:  2006-09-12       Impact factor: 24.094

5.  Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry.

Authors:  David O Williams; J Dawn Abbott; Kevin E Kip
Journal:  Circulation       Date:  2006-10-23       Impact factor: 29.690

6.  An algorithm for use of prasugrel (effient) in patients undergoing cardiac catheterization and percutaneous coronary intervention.

Authors:  Julio Marchini; David Morrow; Frederic Resnic; Andre Manica; James Kirshenbaum; Christopher Cannon; Kevin Croce
Journal:  Crit Pathw Cardiol       Date:  2010-12

7.  Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

Authors:  Jonathan R Nebeker; Renu Virmani; Charles L Bennett; Jennifer M Hoffman; Matthew H Samore; Jorge Alvarez; Charles J Davidson; June M McKoy; Dennis W Raisch; Brian K Whisenant; Paul R Yarnold; Steven M Belknap; Dennis P West; Jonathan E Gage; Richard E Morse; Gordana Gligoric; Laura Davidson; Marc D Feldman
Journal:  J Am Coll Cardiol       Date:  2005-12-01       Impact factor: 24.094

8.  Endothelial dysfunction and restenosis following percutaneous coronary intervention.

Authors:  Panuratn Thanyasiri; Krishna Kathir; David S Celermajer; Mark R Adams
Journal:  Int J Cardiol       Date:  2006-11-07       Impact factor: 4.164

9.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Authors:  M B Leon; D S Baim; J J Popma; P C Gordon; D E Cutlip; K K Ho; A Giambartolomei; D J Diver; D M Lasorda; D O Williams; S J Pocock; R E Kuntz
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

Review 10.  Variability in responsiveness to oral antiplatelet therapy.

Authors:  Dominick J Angiolillo
Journal:  Am J Cardiol       Date:  2009-02-02       Impact factor: 2.778
View more
  1 in total

1.  Very late outcomes of drug-eluting stents coated with biodegradable polymers: insights from the 5-year follow-up of the randomized PAINT trial.

Authors:  Julio F Marchini; Wilton F Gomes; Bruno Moulin; Marco A Perin; Ludmilla A R R Oliveira; J Airton Arruda; Valter C Lima; Antonio A G Lima; Paulo R A Caramori; Cesar R Medeiros; Mauricio R Barbosa; Fabio S Brito; Expedito E Ribeiro; Pedro A Lemos
Journal:  Cardiovasc Diagn Ther       Date:  2014-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.